Teva Pharmaceutical Industries Limited
TEVJF
$29.19
$0.832.93%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.74B | 3.56B | 2.20B | 2.16B | 1.70B |
| Total Receivables | 3.39B | 3.71B | 3.81B | 3.56B | 3.38B |
| Inventory | 3.18B | 3.18B | 3.32B | 3.50B | 3.25B |
| Prepaid Expenses | 1.07B | 1.12B | 1.12B | 1.08B | 1.02B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.33B | 2.38B | 2.29B | 2.31B | 2.18B |
| Total Current Assets | 13.71B | 13.95B | 12.74B | 12.62B | 11.53B |
|
|
|||||
| Total Current Assets | 13.71B | 13.95B | 12.74B | 12.62B | 11.53B |
| Net Property, Plant & Equipment | 4.33B | 4.43B | 5.16B | 5.17B | 4.99B |
| Long-term Investments | 15.82B | 16.00B | 15.95B | 15.95B | 15.48B |
| Goodwill | 15.82B | 16.00B | 15.95B | 15.95B | 15.48B |
| Total Other Intangibles | 3.61B | 3.78B | 3.94B | 4.14B | 4.19B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.57B | 2.60B | 2.08B | 2.25B | 2.23B |
| Total Assets | 40.04B | 40.75B | 39.86B | 40.13B | 38.42B |
|
|
|||||
| Total Accounts Payable | 2.60B | 2.53B | 2.36B | 2.50B | 2.29B |
| Total Accrued Expenses | 5.51B | 6.08B | 6.22B | 6.05B | 5.71B |
| Short-term Debt | 12.00M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.60B | 1.91B | 24.00M | 464.00M | 421.00M |
| Total Finance Division Other Current Liabilities | 2.81B | 2.93B | 2.89B | 2.85B | 2.74B |
| Total Other Current Liabilities | 2.81B | 2.93B | 2.89B | 2.85B | 2.74B |
| Total Current Liabilities | 13.53B | 13.46B | 11.49B | 11.86B | 11.16B |
|
|
|||||
| Total Current Liabilities | 13.53B | 13.46B | 11.49B | 11.86B | 11.16B |
| Long-Term Debt | 14.03B | 15.01B | 16.78B | 16.78B | 16.23B |
| Short-term Debt | 12.00M | -- | -- | -- | -- |
| Capital Leases | 280.00M | 311.00M | 283.00M | 296.00M | 288.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.96B | 4.06B | 4.04B | 4.36B | 4.47B |
| Total Liabilities | 31.81B | 32.83B | 32.60B | 33.30B | 32.15B |
|
|
|||||
| Common Stock & APIC | 28.26B | 28.19B | 28.10B | 28.06B | 28.02B |
| Retained Earnings | -13.39B | -13.76B | -14.24B | -14.68B | -14.96B |
| Treasury Stock & Other | -6.64B | -6.52B | -6.60B | -6.56B | -6.80B |
| Total Common Equity | 8.23B | 7.91B | 7.25B | 6.83B | 6.26B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.23B | 7.91B | 7.25B | 6.83B | 6.26B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 4.00M | 4.00M | 4.00M | 7.00M | 7.00M |
| Total Equity | 8.23B | 7.91B | 7.25B | 6.83B | 6.27B |
|
|
|||||